Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC1102 in Chronic Hepatitis B
NCT03801798Phase 2Unknown
- Sponsor
- GC Biopharma
- Start
- Feb 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 2 trial of GC5103 in Chronic Hepatitis B (CHB), sponsored by GC Biopharma. Status: unknown.
02
Drugs
GC5103
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03801798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801798.